Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B6 for Renal Protection in Sepsis
NCT06008223Completed
- Sponsor
- Huzhou First People's Hospital
- Start
- Nov 2021
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of pyridoxine in sepsis and acute kidney injury (AKI) (2 arms), sponsored by Huzhou First People's Hospital. Primary endpoints: Inflammatory response index at Day 7, Oxidative stress response index at Day 7 and 1 more. Started Nov 2021; status: completed.
02
Drugs
pyridoxine
03
Conditions
sepsisacute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06008223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06008223.